A detailed history of Td Waterhouse Canada Inc. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 232,424 shares of ABCL stock, worth $632,193. This represents 0.0% of its overall portfolio holdings.

Number of Shares
232,424
Previous 245,604 5.37%
Holding current value
$632,193
Previous $681 Million 12.58%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$2.39 - $3.49 $31,500 - $45,998
-13,180 Reduced 5.37%
232,424 $595 Million
Q2 2024

Nov 12, 2024

SELL
$2.73 - $4.73 $46,459 - $80,495
-17,018 Reduced 6.48%
245,604 $681 Million
Q2 2024

Aug 02, 2024

BUY
$2.73 - $4.73 $11,739 - $20,339
4,300 Added 1.66%
262,622 $1.56 Billion
Q1 2024

May 10, 2024

BUY
$4.29 - $5.97 $823 - $1,146
192 Added 0.07%
258,322 $1.13 Billion
Q4 2023

Feb 12, 2024

SELL
$3.91 - $5.93 $279,451 - $423,823
-71,471 Reduced 21.68%
258,130 $1.58 Billion
Q3 2023

Nov 13, 2023

SELL
$4.6 - $7.95 $1.12 Million - $1.94 Million
-244,314 Reduced 42.57%
329,601 $1.52 Billion
Q2 2023

Nov 13, 2023

BUY
$5.66 - $7.59 $516,656 - $692,830
91,282 Added 18.91%
573,915 $4.24 Billion
Q1 2023

Nov 13, 2023

SELL
$7.31 - $11.18 $226,105 - $345,808
-30,931 Reduced 6.02%
482,633 $4.25 Billion
Q4 2022

Nov 13, 2023

SELL
$9.48 - $14.52 $133,630 - $204,673
-14,096 Reduced 2.67%
513,564 $5.77 Billion
Q3 2022

Nov 13, 2023

BUY
$9.2 - $13.68 $1.59 Million - $2.37 Million
173,184 Added 48.86%
527,660 $6.36 Billion
Q2 2022

Nov 13, 2023

SELL
$5.72 - $10.65 $12,298 - $22,897
-2,150 Reduced 0.6%
354,476 $4.55 Billion
Q1 2022

Nov 13, 2023

BUY
$7.46 - $14.14 $1.31 Million - $2.48 Million
175,671 Added 97.08%
356,626 $4.28 Billion
Q4 2021

Nov 13, 2023

BUY
$12.99 - $17.73 $2.35 Million - $3.21 Million
180,955 New
180,955 $2.84 Billion

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $776M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.